| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |